Novo Nordisk’s Wegovy Pill Emerges as Engagement Champion
Pharma brands made a significant impact during the 2026 Super Bowl, with Novo Nordisk’s Wegovy pill advertisement leading the charge in consumer engagement. The commercial, which marked Novo’s first-ever Super Bowl spot, aired in the fourth quarter and featured a star-studded cast including Kenan Thompson, Ana Gasteyer, DJ Khaled, Danielle Brooks, Danny Trejo, and John C. Reilly.
According to data from TV outcomes company EDO, the Wegovy ad generated 3.7 times more engagement than the median Super Bowl commercial, placing it 10th overall in effectiveness across all industries. Despite a broader trend in pharma marketing moving away from product-specific messaging, Novo’s 90-second promotion for its oral obesity medication resonated strongly with viewers, demonstrating the power of celebrity-led campaigns and emotive storytelling.
Shifting Strategies in Pharma Marketing
Experts noted a shift in strategy among pharma brands during this year’s Super Bowl. Heather Coyle, president at Triggers brand growth consultancy, emphasized that the focus was less about immediate conversions and more on building trust and cultural relevance.
“This year’s Super Bowl ads weren’t focused on driving immediate conversion, but on building trust and cultural relevance at scale,” Coyle explained. “Pharma now sees brand as a long-term competitive moat, rather than a nice-to-have.”
She added that healthcare brands are increasingly recognizing that behavior change stems from emotional permission, not just clinical data. This strategic pivot was evident in the mix of disease awareness campaigns and emotionally resonant narratives that aired during the game.
Other Pharma Players Join the Field
Alongside Novo, Boehringer Ingelheim and Novartis also made notable appearances. Boehringer’s disease awareness campaign featured Octavia Spencer and Sofía Vergara in a buddy-comedy style commercial urging viewers to discuss urine albumin-to-creatinine ratio testing with their doctors, aiming to detect early signs of heart or kidney risks. The 30-second spot ranked 23rd in engagement, generating 2.1 times more engagement than the median Super Bowl ad.
Meanwhile, Novartis continued its push for prostate cancer awareness with a humorous campaign titled “Relax your Tight End,” starring current and former NFL tight ends. Although the ad ranked 75th in engagement, it scored the highest in likeability among pharma ads, with an iSpot rating of 643. Nearly 30% of viewers cited the message as the best part of the ad, reflecting a strong connection with the audience.
Direct-to-Consumer Telehealth Brands Make Their Mark
Telehealth companies Hims & Hers and Ro also capitalized on the Super Bowl stage. Hims & Hers aired a provocative ad featuring rapper and actor Common, highlighting disparities in healthcare access with the tagline “Rich people live longer.” The ad emphasized that with Hims & Hers, average Americans can access diagnostic tests and weight loss treatments without special connections. It ranked 19th in engagement, delivering 2.2 times more impact than the median commercial.
Ro’s debut ad featured tennis legend Serena Williams promoting its GLP-1 medication services. Though the ad ranked just below Novartis at 76th, it still performed better than Eli Lilly’s spot, which landed at 78th with its “Watch This” campaign showcasing confident Zepbound users.
Regular Season Campaigns See Strong Pharma Performance
While some pharma ads fell short during the Super Bowl, others triumphed during the 2025-26 NFL regular season. EDO reported that Eli Lilly’s Zepbound campaign was 519% more effective than the average pharma ad during the season. Its “Bridge V2” commercial stood out, outperforming even top ads from Ro, Regeneron, Dexcom, and Johnson & Johnson.
Pharma ads aired during NFL broadcasts were found to be 104% more effective than those shown during prime-time programming. Overall, pharma advertising during the football season was 9% more effective than the previous year, with brands broadcasting ads 332 times—a 13% increase year-over-year.
These statistics underscore the growing importance of emotionally resonant, strategically placed advertising in the pharma sector, particularly during high-visibility events like the Super Bowl and NFL broadcasts.
This article is inspired by content from Original Source. It has been rephrased for originality. Images are credited to the original source.